RAJAH VIGNESH (SVP and CMO) received a stock award from Y-MABS THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/19/2023ACC: 0001104659-23-005038
Officer· SVP and CMO
Since Jun 2020
+53.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
53.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+17.80K
Price / share
—
Trade value
—
% of position
New position
1/17/2023
0.00→17.80K
Total
Net shares
+17.80K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/17/2023 | A · Award | +17.80K | — | — | New position | 0.00 | 17.80K |
| Total | +17.80K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common stock
35.70K shares
Shares
+35.70K
Strike price
4.70
Held after
35.70K
Exercisable
—
1/17/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common stock35.70K shares | 1/17/2023 | A · Award | +35.70K | 4.70 | — | 35.70K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned4.27K
Total
4.27K indirect4.27K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 4.27K | Indirect |
| Total | 4.27K | 4.27K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported